Melasma, Vitiligo, Post Inflammatory hyperpigmentation, Lentigo are some of the common pigmentary disorders that has been of cosmetic concern to many. At CIDP, we propose various protocols to substantiate claims across these pathologies. Over the past 19 years, CIDP has conducted over 30 studies on melasma, a skin condition characterised by light to dark brown or brown-grey coloured patches with symmetrical distribution involving the central part of the face including forehead, cheeks, nose, and chin.
Studies involving the comparative efficacy of novel treatments (including hydroquinone) or therapies in improving skin pigmentation are conducted at CIDP under regulated norms.
Our highly trained dermatologists and experts can visually assess the intensity, size, and homogeneity of pigmentary areas through standardised scales (MASI, MSS, PAHPI, VAS). Furthermore, our recent investment, the new upgraded VISIA CR5 now allows for even better imaging to illustrative claims or for image analysis.
Kirsty Doolan 12 February 2025 We examine what's new in tropical and ingestible beauty products…
10 February 2025 IFF announces the launch of its new artificial intelligence (AI)-powered search tool:…
Renata Martins 6 February 2025 The global cosmetics market is evolving rapidly with an influx…